| 1 |
Christopher JL Murray GA, Stevens LA. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet, 2020, 396(10258): 1204-1222.
|
| 2 |
王亚楠, 吴思缈, 刘鸣. 中国脑卒中15年变化趋势和特点 [J]. 华西医学, 2021, 36(6): 803-807.
|
| 3 |
陈亚荣, 尹春, 黄佩瑶, 等. 糖尿病与脑卒中发病风险的前瞻性研究 [J]. 中华疾病控制杂志, 2022, 26(1): 74-79.
|
| 4 |
Gray CS, Scott JF, French JM, et al. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke [J]. Age Ageing, 2004, 33(1): 71-77.
|
| 5 |
Bhaskar S. Impact of obesity-induced type 2 diabetes on long-term outcomes following stroke [J]. Clin Sci (Lond), 2019, 133(14): 1603-1607.
|
| 6 |
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease [J]. Diabetes, 1988, 37(12): 1595-1607.
|
| 7 |
James DE, Stöckli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance [J]. Nat Rev Mol Cell Biol, 2021, 22(11): 751-771.
|
| 8 |
Sánchez-Iñigo L, Navarro-González D, Fernández-Montero A, et al. Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort [J]. Int J Stroke, 2017, 12(2): 187-191.
|
| 9 |
Cho IY, Chang Y, Sung E, et al. Weight change and the development of nonalcoholic fatty liver disease in metabolically healthy overweight individuals [J]. Clin Gastroenterol Hepatol, 2022, 20(3): e583-e599.
|
| 10 |
Meigs JB. Epidemiology of the insulin resistance syndrome [J]. Curr Diab Rep, 2003, 3(1): 73-79.
|
| 11 |
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J]. Circulation, 2009, 120(16): 1640-1645.
|
| 12 |
Tagi VM, Chiarelli F. Obesity and insulin resistance in children [J]. Curr Opin Pediatr, 2020, 32(4): 582-588.
|
| 13 |
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance [J]. Physiol Rev, 2018, 98(4): 2133-2223.
|
| 14 |
Paccoud R, Saint-Laurent C, Piccolo E, et al. SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations [J]. Sci Transl Med, 2021, 13(591):eabe2587.
|
| 15 |
Pomytkin I, Costa-Nunes JP, Kasatkin V, et al. Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment [J]. CNS Neurosci Ther, 2018, 24(9): 763-774.
|
| 16 |
Peineau S, Taghibiglou C, Bradley C, et al. LTP inhibits LTD in the hippocampus via regulation of GSK3beta [J]. Neuron, 2007, 53(5): 703-717.
|
| 17 |
韩芸峰, 来璇, 杨军, 等. 代谢综合征与血管性认知障碍关系的研究进展 [J/OL]. 中华脑血管病杂志(电子版), 2020, 14(4): 234-237.
|
| 18 |
Owei I, Jain N, Jones D, et al. Physiology of glycemic recovery and stabilization after hyperinsulinemic euglycemic clamp in healthy subjects [J]. J Clin Endocrinol Metab, 2018, 103(11): 4155-4162.
|
| 19 |
Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage [J]. Am J Physiol Endocrinol Metab, 2008, 294(1): E15-E26.
|
| 20 |
Fitzgibbons TP, Czech MP. Emerging evidence for beneficial macrophage functions in atherosclerosis and obesity-induced insulin resistance [J]. J Mol Med (Berl), 2016, 94(3): 267-275.
|
| 21 |
Gaillard T, Miller E. Guidelines for stroke survivors with diabetes mellitus [J]. Stroke, 2018, 49(6): e215-e217.
|
| 22 |
Thacker EL, Psaty BM, McKnight B, et al. Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults [J]. Stroke, 2011, 42(12): 3347-3351.
|
| 23 |
Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies [J]. Lancet, 2010, 375(9733): 2215-2222.
|
| 24 |
Zabala A, Darsalia V, Lind M, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study [J]. Cardiovasc Diabetol, 2021, 20(1): 202.
|
| 25 |
Kwok MK, Kawachi I, Rehkopf D, et al. The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study [J]. BMC Med, 2020, 18(1): 363.
|
| 26 |
Dearborn JL, Viscoli CM, Inzucchi SE, et al. Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease [J]. Int J Stroke, 2019, 14(6): 639-645.
|
| 27 |
Åberg D, Åberg ND, Jood K, et al. Homeostasis model assessment of insulin resistance and outcome of ischemic stroke in non-diabetic patients - a prospective observational study [J]. BMC Neurol, 2019, 19(1): 177.
|
| 28 |
Mi D, Wang Y, Wang Y, et al. Insulin resistance is an independent risk factor for early neurological deterioration in non-diabetic patients with acute ischemic stroke [J]. Neurol Sci, 2020, 41(6): 1467-1473.
|
| 29 |
Wieberdink RG, Koudstaal PJ, Hofman A, et al. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly [J]. Am J Epidemiol, 2012, 176(8): 699-707.
|
| 30 |
Gerstein HC, Ferrannini E, Riddle MC, et al. Insulin resistance and cardiovascular outcomes in the ORIGIN trial [J]. Diabetes Obes Metab, 2018, 20(3): 564-570.
|
| 31 |
Gu T, Yang Q, Ying G, et al. Lack of association between insulin resistance as estimated by homeostasis model assessment and stroke risk: a systematic review and meta-analysis [J]. Med Hypotheses, 2020, 141: 109700.
|
| 32 |
Chang Y, Kim CK, Kim MK, et al. Insulin resistance is associated with poor functional outcome after acute ischemic stroke in non-diabetic patients [J]. Sci Rep, 2021, 11(1): 1229.
|
| 33 |
Ago T, Matsuo R, Hata J, et al. Insulin resistance and clinical outcomes after acute ischemic stroke [J]. Neurology, 2018, 90(17): e1470-e1477.
|
| 34 |
Jing J, Pan Y, Zhao X, et al. Insulin resistance and prognosis of nondiabetic patients with ischemic stroke: The ACROSS-China Study (Abnormal Glucose Regulation in Patients With Acute Stroke Across China) [J]. Stroke, 2017, 48(4): 887-893.
|
| 35 |
Baron AD, Steinberg HO, Chaker H, et al. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans [J]. J Clin Invest, 1995, 96(2): 786-792.
|
| 36 |
Sakai S, Tanimoto K, Imbe A, et al. Decreased β-cell function is associated with reduced skeletal muscle mass in Japanese subjects without diabetes [J]. PLoS One, 2016, 11(9): e0162603.
|
| 37 |
Yaghi S, Furie KL, Viscoli CM, et al. Pioglitazone prevents stroke in patients with a recent transient ischemic attack or ischemic stroke: a planned secondary analysis of the IRIS trial (insulin resistance intervention after stroke) [J]. Circulation, 2018, 137(5): 455-463.
|
| 38 |
Kim BJ, Lee SH, Jung KH, et al. Dynamics of obesity paradox after stroke, related to time from onset, age, and causes of death [J]. Neurology, 2012, 79(9): 856-863.
|
| 39 |
Niewada M, Michel P. Lifestyle modification for stroke prevention: facts and fiction [J]. Curr Opin Neurol, 2016, 29(1): 9-13.
|
| 40 |
Mirabelli M, Chiefari E, Arcidiacono B, et al. Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases [J]. Nutrients, 2020, 12(4)
|
| 41 |
Tettamanzi F, Bagnardi V, Louca P, et al. A high protein diet is more effective in improving insulin resistance and glycemic variability compared to a mediterranean diet-a cross-over controlled inpatient dietary study [J]. Nutrients, 2021, 13(12):4380.
|
| 42 |
张晓晓, 郑跃, 马玲,等. 有氧运动训练对脑卒中患者胰岛素抵抗及认知水平的影响 [J]. 中国医刊, 2020, 55(4): 434-437.
|
| 43 |
Inzucchi SE, Viscoli CM, Young LH, et al. Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease [J]. Diabetes Care, 2016, 39(10): 1684-1692.
|
| 44 |
Hung YC, Chiu LT, Huang HY, et al. Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study [J]. Cardiovasc Diabetol, 2020, 19(1): 94.
|
| 45 |
Spence JD, Viscoli CM, Inzucchi SE, et al. Pioglitazone therapy in patients with stroke and prediabetes: a post hoc analysis of the IRIS randomized clinical trial [J]. JAMA Neurol, 2019, 76(5): 526-535.
|
| 46 |
Kaku K, Wanner C, Anker SD, et al. The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease [J]. Diabetes Obes Metab, 2022, 24(4): 662-674.
|
| 47 |
Ji L, Dong X, Li Y, et al. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as add-on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30-week, double-blind, phase 3a, randomized trial [J]. Diabetes Obes Metab, 2021, 23(2): 404-414.
|